Three IGNITE PIs presented at Precision Medicine Conference
Julie Johnson, PharmD, Carol Horowitz, M.D., M.P.H., and Josh Denny, M.D., were three of the presenters at the University of Florida Precision Medicine Conference, held March 6-7, 2019 in Orlando, Florida. This conference brings together clinicians, researchers and other thought leaders from medicine and pharmacy to receive cutting edge guidance from professionals with experience implementing genomic medicine and pharmacogenomics in a variety of settings.
PHASeR: A collaboration in PGx to help veterans
There are about 15 million cancer survivors in the United States; about 400,000 of them are also veterans in the Veterans Affairs (VA) system. As more people survive cancer, their medication needs go beyond their cancer treatment. For veterans, VA physicians hope to bring more personalization to cancer survivorship plans for patients with pharmacogenetic testing. Read more on CAGPM website
Evaluating Genomic Medicine Interventions
The IGNITE I Network funded six genomic medicine projects. Through varied interventions, Lori Orlando, M.D., and team hypothesized that synergies across projects could be leveraged to better understand participants’ experiences with genomic medicine interventions. The team performed cross-network analyses to identify associations between participant demographics and attitudes toward the intervention, plan to share results, and quality of life. Their results were published online on March 20, 2019, in Molecular Genetics & Genomic Medicine.
Ginsburg presented at 1st Macrogen and LKCMedicine Scientific Conference
Geoff Ginsburg, M.D., Ph.D., presented at the one-day scientific conference “Applications of Genomic Advances in Healthcare” on March 18, 2019, in Singapore. His presentation was entitled, “Achieving Impact of Precision Medicine Locally, Nationally and Internationally.”
The conference featured invited speakers from all over the world, including the United States, Finland, Germany, Thailand and Singapore to share their knowledge and experiences on how genomics can be applied to populations, pathways and people.